The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Barriers and facilitators to the implementation of routine ototoxicity screening for head and neck cancer patients.
 
Priya Bapat
No Relationships to Disclose
 
Pansy Chow
No Relationships to Disclose
 
Katrina Hueniken
No Relationships to Disclose
 
Mary Mahler
No Relationships to Disclose
 
M. Catherine Brown
No Relationships to Disclose
 
Carolyn Falls
No Relationships to Disclose
 
Andrew J. Hope
Travel, Accommodations, Expenses - Elekta
 
Aaron Richard Hansen
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
David Paul Goldstein
Stock and Other Ownership Interests - CVS (I); Johnson & Johnson (I); Merck (I); Pfizer (I)
 
John Rutka
No Relationships to Disclose
 
Doris Howell
No Relationships to Disclose
 
Wei Xu
No Relationships to Disclose
 
Geoffrey Liu
Honoraria - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; novartis; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca
Research Funding - roche (Inst)